接受与未接受治疗的原发性人类免疫缺陷病毒感染中脑体积与皮质厚度的纵向变化轨迹
研究对65例原发性HIV感染(PHI)者纵向行磁共振成像,其中30例随访中启动联合抗逆转录病毒治疗(cART),并与16例慢性HIV感染(CHI)者及19例HIV未感染者比较。结果显示未治疗时间越长,丘脑、尾状核、小脑体积损失及额颞叶与扣带回皮质变薄越明显;启动cART后未见进一步体积损失,额颞叶皮质厚度小幅增加与cART持续时间较长相关,PHI组丘脑、尾状核、壳核及皮质灰质体积大于CHI组。
要点
- 未治疗时间越长,丘脑、尾状核、小脑体积损失及额颞叶与扣带回皮质变薄越明显。
- 启动cART后未再观察到进一步脑体积损失。
- PHI组丘脑、尾状核、壳核及皮质灰质体积大于CHI组。
核心结论
- 未治疗期间可出现皮质下萎缩与皮质变薄,cART可能使其停止,研究强调早期cART的重要性。
研究设计与样本
- 65例PHI期间入组者接受纵向磁共振成像,其中30例在随访期间启动cART。
- 横断面比较纳入16例CHI患者与19例HIV未感染者。
- 采用基于张量的形态测量与皮质建模分别估计脑体积与皮质厚度。
- 使用混合效应模型纵向描绘cART前后脑结构变化,并检验脑形态测量值与血液及脑脊液生物标志物的关系。
主要发现
- cART前,PHI中未治疗感染持续时间较长与丘脑、尾状核和小脑体积损失相关,并与额叶、颞叶及扣带皮质变薄相关。
- cART后未观察到进一步体积损失,但额叶与颞叶皮质厚度小幅增加与较长cART持续时间相关。
- 未观察到脑形态测量值与血液或脑脊液指标的相关性。
- PHI组与HIV未感染组的脑形态测量值无差异,但PHI组丘脑、尾状核、壳核及皮质灰质体积大于CHI参与者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human immunodeficiency virus (HIV) penetrates the brain in early infection. We used neuroimaging to longitudinally examine the impact of HIV and combination antiretroviral therapy (cART) on the brain in treated and untreated HIV-infected participants, starting in primary HIV infection (PHI). METHODS: Sixty-five participants, enrolled during PHI, underwent longitudinal magnetic resonance imaging, 30 of whom commenced cART during follow-up. Cross-sectional data from 16 patients with chronic HIV infection (CHI) and 19 HIV-uninfected participants were included for comparison. Brain volume and cortical thickness were estimated using tensor-based morphometry and cortical modeling, respectively. Mixed-effects models longitudinally mapped structural brain changes before and after cART. The relationship between brain morphometry estimates and blood and cerebrospinal fluid (CSF) biomarkers were also tested. Region-of-interest analyses were performed to compare brain morphometry estimates between the groups. RESULTS: Prior to cART, longer duration of untreated infection in PHI correlated with volume loss in the thalamus, caudate, and cerebellum, and with cortical thinning in the frontal and temporal lobes and cingulate cortex. After cART, no further volume loss was observed. However, small increases of cortical thickness in the frontal and temporal lobe correlated with longer cART duration. No correlations were observed with blood or CSF measures. The PHI group did not have different brain morphometric measures compared to the HIV-uninfected group, but had larger volumes in the thalamus, caudate, putamen, and cortical gray matter compared with CHI participants. CONCLUSIONS: Subcortical atrophy and cortical thinning occur during untreated infection but may be arrested by cART. These findings emphasize the importance of early cART.
引用
- Sanford R, Ances BM, Meyerhoff DJ, et al. Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection. Clin Infect Dis. 2018. PMID: 29697762. doi:10.1093/cid/ciy362
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。